Site icon pharmaceutical daily

2020 RNA Therapies in Oncology Analytical Tool – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “RNA Therapies in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering.

RNA Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot and fast moving area of oncology.

This unique product is truly the only tool of its kind and is designed to give you a competitive edge in your RNA therapy drug surveillance and intelligence, allowing you to power your decision making and advance your own interests.

RNA therapies, such as miRNA, RNAi & siRNA, is an emerging class of biopharmaceutical that has immense potential in cancer medicine. Critical to the field, recent developments in delivery technologies such nanoparticle carriers and conjugation strategies have allowed RNA therapeutics to enter clinical trials in the treatment of cancer.

Your RNA Therapies in Oncology: Analytical Tool covers more than 127 companies plus partners who are today developing 274 RNA therapy drugs, 182 of which are in active development in cancer across 122 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.

RNA Therapies in Oncology: Analytical Tool achieves this by continuously scanning development in RNA therapy and reporting:

Identify, prioritize, and lead scientific assessment of oncology opportunities and competition by multiple factors such as:

Your key to access development at the world-leading cancer meetings

The RNA Therapies in Oncology: Analytical Tool is continuously updated according to twelve of the world’s most influential meetings in oncology (AACR, ASCO, ASGCT, ASH, CMIT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you are not able to attend any of the conference(s) in person, this Analytical Tool ensures that you are not missing out on the important take home messages you need to know about.

Run combination therapy analysis like no other

The RNA Therapies in Oncology: Analytical Tool delivers comprehensive combination therapy analysis, allowing you to analyze combination therapies from multiple perspectives; from a single drug to virtually any cross section of oncology drugs of interest.

Unparalleled biomarker surveillance

We also provide an outstanding oncology clinical biomarker surveillance & analysis, highlighting clinical phenotyping and patient stratification in trials. This analysis is based on our monitoring of the presence and usage of more than 1,000 biomarkers across tens of thousands of cancer clinical trials.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of online access to twice-weekly updates in both contents and features, pipeline alerts and online support.

For more information about this report visit https://www.researchandmarkets.com/r/ai2rpm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version